Daliresp

RxNorm concept 1091840, brand name (bn).

RxCUI: 1091840
Term type: Brand name (BN)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/1091840 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

roflumilast 1091836

Related concepts

roflumilast 0.5 MG [Daliresp] (SBDC, ingredient of)
roflumilast Oral Tablet [Daliresp] (SBDF, ingredient of)
roflumilast 0.5 MG Oral Tablet [Daliresp] (SBD, ingredient of)
Daliresp Oral Product (SBDG, ingredient of)
Daliresp Pill (SBDG, ingredient of)
roflumilast 0.25 MG [Daliresp] (SBDC, ingredient of)
roflumilast 0.25 MG Oral Tablet [Daliresp] (SBD, ingredient of)
roflumilast (IN, tradename of)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 1091840 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/1091840 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 1091840. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.